{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:30:14Z","timestamp":1791210614112,"version":"4.1.0"},"reference-count":36,"publisher":"Wiley","issue":"14","license":[{"start":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T00:00:00Z","timestamp":1428969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["R03CA15 6561"],"award-info":[{"award-number":["R03CA15 6561"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2015,7,15]]},"abstract":"<jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>The current analysis follows the implementation of Public Law 107\u2010260, the Benign Brain Tumor Cancer Registries Amendment Act, which mandated the collection of nonmalignant brain tumors.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Meningiomas were selected from the Surveillance, Epidemiology, and End Results (SEER) Program database for the years 2004 to 2011. Demographic and clinical characteristics, initial treatment patterns, and survival outcomes were evaluated using surveillance epidemiology statistical methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>The average annual age\u2010adjusted incidence rate per 100,000 population was 7.62 (95 % confidence interval [CI], 7.55\u20107.68) for all meningiomas, 7.18 (95% CI, 7.12\u20107.25) for benign meningiomas, 0.32 (95% CI, 0.31\u20100.33) for borderline malignant meningiomas, and 0.12 (95% CI, 0.11\u20100.12) for malignant meningiomas. The annual rates increased for benign and borderline malignant tumors but decreased for malignant tumors. The rates for women exceeded those for men, especially for those with benign meningiomas. Black race was associated with significantly higher rates as was advancing age. Greater than 80% of tumors were located in cerebral meninges. Diagnostic confirmation through pathology occurred for approximately 50% of benign tumors, 90% of borderline malignant tumors, and 80% of malignant tumors. No initial treatment was reported for greater than 60% of benign tumors, 29% of borderline malignant tumors, or 31% of malignant tumors. The 5\u2010year relative survival estimates for benign tumors, borderline malignant tumors, and malignant tumors were 85.6% (95% confidence interval [CI], 85%\u201086.2%), 82.3% (95% CI, 79.3%\u201084.8%), and 66% (95% CI, 60.6%\u201070.9%), respectively. Predictors of poorer survival were advanced age, being male gender, black race, no initial treatment, and malignant tumor behavior.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>The current analysis demonstrates that there is an increasing incidence of nonmalignant meningiomas, probably because of reporting learning curves associated with the implementation of Public Law 107\u2010260. The high proportion of cases who receive no initial treatment is a survival outcome concern, especially for patients with malignant meningiomas. <jats:bold><jats:italic>Cancer<\/jats:italic> 2015;121:2400\u20132410.<\/jats:bold> \u00a9 <jats:italic>2015 American Cancer Society<\/jats:italic>.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.29379","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T17:01:53Z","timestamp":1429030913000},"page":"2400-2410","source":"Crossref","is-referenced-by-count":104,"title":["Epidemiology of meningiomas post\u2010Public Law 107\u2010206: The Benign Brain Tumor Cancer Registries Amendment Act"],"prefix":"10.1002","volume":"121","author":[{"given":"Therese A.","family":"Dolecek","sequence":"first","affiliation":[{"name":"Division of Epidemiology and Biostatistics and Institute for Health Research and Policy School of Public Health University of Illinois at Chicago Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Van Meter","family":"Dressler","sequence":"additional","affiliation":[{"name":"Division of Cancer Biostatistics University of Kentucky Lexington Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigisha P.","family":"Thakkar","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Kentucky Lexington Kentucky"},{"name":"Department of Neurology University of Kentucky Lexington Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Cancer Biostatistics University of Kentucky Lexington Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Al\u2010Qaisi","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Kentucky Lexington Kentucky"},{"name":"Department of Neurology University of Kentucky Lexington Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Villano","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Kentucky Lexington Kentucky"},{"name":"Department of Neurology University of Kentucky Lexington Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,4,14]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"Benign Brain Tumor Cancer Registries Amendment Act Public Law No. 107\u2010260 42 USC 280e."},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-007-0243-4"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199712000-00008"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not151"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-3019(87)90005-X"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2000.92.5.0766"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070972"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2006.105.4.538"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920915)70:6<1568::AID-CNCR2820700621>3.0.CO;2-Y"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-3019(86)90233-8"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1985.62.1.0018"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.20.1.22"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00317-9"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1994.80.2.0195"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-009-0034-5"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.123.3.453"},{"key":"e_1_2_7_19_1","volume-title":"International Classification of Diseases for Oncology","author":"Fritz A","year":"2000"},{"key":"e_1_2_7_20_1","volume-title":"Race and Ethnicity Work Group. NAACCR Guideline for Enhancing Hispanic\/Latino Identification: Revised NAACCR Hispanic\/Latino Identification Algorithm (NHIA v2.2.1)","author":"The North American Association of Central Cancer Registries (NAACCR)","year":"2011"},{"key":"e_1_2_7_21_1","unstructured":"Surveillance Research Program National Cancer Institute. SEER*Stat software version 8.1.5 [software program]. Available at:www.seer.cancer.gov\/seerstat. Accessed November 1 2014."},{"key":"e_1_2_7_22_1","unstructured":"Surveillance Epidemiology and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database: Incidence\u2010SEER 18 Regs Research Data\u2009+\u2009Hurricane Katrina Impacted Louisiana Cases November 2013 submission (2000\u20102011) <Katrina\/Rita Population Adjustment>\u2010Linked to County Attributes\u2010Total US 1969\u20102012 Counties (released April 2014 updated May 7 2014; based on the November 2013 submission). Bethesda MD: National Cancer Institute DCCPS Surveillance Research Program Surveillance Systems Branch;2014."},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/0962280206070621"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z"},{"key":"e_1_2_7_25_1","unstructured":"National Cancer Institute.Joinpoint Regression Program version 4.1.1 [software program]. Bethesda MD: National Cancer Institute DCCPS Statistical Research and Applications Branch;2014."},{"key":"e_1_2_7_26_1","volume-title":"and End Results (SEER) Program (www.seer.cancer.gov). Research Data (1973\u20102011), released April 2014, based on the November 2013 submission","author":"Surveillance, Epidemiology","year":"2014"},{"key":"e_1_2_7_27_1","volume-title":"IBM SPSS Statistics for Windows, version 21.0 [software package]","author":"IBM Corporation","year":"2012"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470258019"},{"key":"e_1_2_7_29_1","first-page":"32","article-title":"The impact of the Benign Brain Tumor Cancer Registries Amendment Act (Public Law 107\u2010260) on non\u2010malignant brain and central nervous system tumor incidence trends","volume":"40","author":"McCarthy BJ","year":"2013","journal-title":"J Registry Manag"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.3171\/FOC-07\/10\/E2"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930801)72:3<639::AID-CNCR2820720304>3.0.CO;2-P"},{"key":"e_1_2_7_32_1","first-page":"6137","article-title":"Risk factors for gliomas and meningiomas in males in Los Angeles County","volume":"49","author":"Preston\u2010Martin S","year":"1989","journal-title":"Cancer Res"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604438"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.3171\/2011.3.JNS101748"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1998.88.5.0831"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-3019(86)90259-4"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0b013e31822d408a"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.29379","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.29379","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.29379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T21:29:51Z","timestamp":1760304591000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.29379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,14]]},"references-count":36,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2015,7,15]]}},"alternative-id":["10.1002\/cncr.29379"],"URL":"https:\/\/doi.org\/10.1002\/cncr.29379","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,14]]}}}